RGBPP Regen Biopharma, Inc.
Fundamentals / CIK 0001589150 / USDRegen Biopharma, Inc. reported $237K in revenue and a net loss of $1.19M for the trailing twelve months ended June 30, 2026 (flat year over year), with a -339.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RGBPP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$237K 0.0% YoY
-
Operating Income TTM-$804K -339.8% margin
-
Net Income TTM-$1.19M -501.4% net margin
-
Diluted EPS TTM-$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$239 Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $237K | $237K | $127K | $126K | $61K | $110K | $110K | $100K | $110K | $100K |
| Research & Development | $12K | $154K | $212K | $158K | $37K | $13K | $46K | $374K | $1.15M | $671K |
| Total Operating Expenses | $575K | $654K | $924K | -- | -- | -- | -- | -- | -- | -- |
| Operating Income | -$339K | -$417K | -$687K | -$340K | -$201K | -$209K | -$757K | -$1.43M | -$2.51M | -$2.96M |
| Interest Income | -- | -- | -- | -- | -- | $0 | $1.3K | -- | -- | -- |
| Interest Expense | $158K | $72K | $59K | $139K | $316K | $333K | $295K | $259K | $99K | $28K |
| Income Before Tax | -$1.27M | -$668K | $1.16M | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | -$1.27M | -$668K | $1.16M | $2.44M | -$6.77M | $3.41M | -$2.62M | -$4.72M | -$5.84M | -$7.75M |
| Basic EPS | -$0.05 | -$0.16 | $0.29 | $0.71 | -$0.00 | $0.00 | -$0.00 | -$0.03 | -$0.04 | -$0.06 |
| Diluted EPS | -$0.05 | -$0.16 | $0.29 | $0.71 | -$0.00 | $0.00 | -$0.00 | -$0.03 | -$0.04 | -$0.06 |
| Basic Shares Outstanding | 23.5M | 4.1M | 3.5M | 3.1M | 3.01B | 1.41B | 2.07B | 152.1M | 141.4M | 127.8M |
| Diluted Shares Outstanding | 23.5M | 4.1M | 3.5M | 3.1M | -- | -- | -- | -- | -- | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $59K | $59K | $59K | $59K | $59K | $59K | $59K | $59K |
| Research & Development | $0 | $2.2K | $210K | $12K | $0 | $0 | $0 | $34K |
| Total Operating Expenses | $35K | $213K | $611K | $182K | $100K | $172K | $120K | $145K |
| Operating Income | $25K | -$154K | -$552K | -$123K | -$41K | -$113K | -$61K | -$85K |
| Interest Expense | $30K | $27K | $27K | $86K | $25K | $22K | $25K | $20K |
| Income Before Tax | -$638K | $992K | -$968K | -$572K | -$167K | -$19K | -$515K | -$271K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Net Income | -$638K | $992K | -$968K | -$572K | -$167K | -$19K | -$515K | -$271K |
| Basic EPS | $0.00 | $0.00 | -$0.01 | -- | -$0.01 | $0.00 | -$0.13 | -- |
| Diluted EPS | $0.00 | $0.00 | -$0.01 | -- | -$0.01 | $0.00 | -$0.13 | -- |
| Basic Shares Outstanding | 615.6M | 184.9M | 99.6M | -- | 23.8M | 21.6M | 4.1M | -- |
| Diluted Shares Outstanding | 615.6M | 184.9M | 99.6M | -- | 23.8M | 21.6M | 4.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $70K | $716 | $121K | $51K | $727K | $0 | $7.9K | $8.0K | $270K | $25K |
| Cash & Short-Term Investments | $70K | $716 | $121K | $51K | $727K | $0 | $7.9K | $8.0K | $270K | $25K |
| Accounts Receivable, Net | $205K | $95K | $0 | $254K | $213K | $103K | $71K | $0 | $0 | $83K |
| Total Current Assets | $275K | $143K | $131K | $336K | $994K | $103K | $79K | $43K | $478K | $207K |
| Long-Term Investments | -- | $18K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $0 | $18K | $223K | $223K | $218K | $20K | $20K | $166K | $466K | $112K |
| Total Assets | $275K | $161K | $354K | $559K | $1.21M | $123K | $99K | $209K | $944K | $319K |
| Accounts Payable | $1.7K | $30K | $30K | $29K | $91K | $110K | $92K | $81K | $496K | $241K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | $107K |
| Deferred Revenue (Current) | $1.34M | $1.47M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | $100K | $21K | $21K | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $6.56M | $5.38M | $5.31M | $8.60M | $14.70M | $7.46M | $11.00M | $8.67M | $5.86M | $799K |
| Total Non-Current Liabilities | $0 | $0 | $150K | $0 | $0 | $0 | $5.0K | $657K | $332K | $107K |
| Total Liabilities | $6.56M | $5.38M | $5.46M | $8.60M | $14.70M | $7.46M | $11.01M | $9.33M | $6.20M | $906K |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $107K |
| Common Stock | $3.9K | $527 | $352 | $503K | $435K | $160K | $60K | $18K | $14K | $14K |
| Retained Earnings | -$21.69M | -$20.42M | -$19.75M | -$20.91M | -$23.35M | -$16.58M | -$20.00M | -$17.46M | -$12.74M | -$20.22M |
| Accumulated Other Comp. Income | -$223K | -$205K | -- | -- | -- | -- | $0 | $53K | $88K | -$80K |
| Total Stockholders' Equity | -$6.28M | -$5.22M | -$5.10M | -$8.04M | -$13.49M | -$7.33M | -$10.91M | -$9.12M | -$5.25M | -$587K |
| Total Equity | -$6.28M | -$5.22M | -$5.10M | -$8.04M | -$13.49M | -$7.33M | -$10.91M | -$9.12M | -$5.25M | -$587K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $239 | $271 | $4.6K | $70K | $1.8K | $1.8K | $135 | $716 |
| Cash & Short-Term Investments | $239 | $271 | $4.6K | $70K | $1.8K | $1.8K | $135 | $716 |
| Accounts Receivable, Net | $287K | $260K | $232K | $205K | $177K | $150K | $122K | $95K |
| Total Current Assets | $288K | $260K | $237K | $275K | $179K | $152K | $174K | $143K |
| Long-Term Investments | -- | -- | -- | -- | $18K | -- | -- | $18K |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $18K | $18K | $18K | $18K |
| Total Assets | $288K | $260K | $237K | $275K | $197K | $169K | $191K | $161K |
| Accounts Payable | $21K | $20K | $11K | $1.7K | $30K | $34K | $36K | $30K |
| Deferred Revenue (Current) | $1.24M | $1.28M | $1.31M | $1.34M | $1.37M | -- | -- | $1.47M |
| Other Current Liabilities | $100K | $100K | $100K | $100K | $21K | $21K | $21K | $21K |
| Total Current Liabilities | $6.17M | $5.62M | $6.81M | $6.56M | $6.01M | $5.87M | $5.87M | $5.38M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $6.17M | $5.62M | $6.81M | $6.56M | $6.01M | $5.87M | $5.87M | $5.38M |
| Common Stock | $113K | $35K | $11K | $3.9K | $3.2K | $2.2K | $2.2K | $527 |
| Retained Earnings | -$22.31M | -$21.67M | -$22.66M | -$21.69M | -$21.12M | -$20.95M | -$20.93M | -$20.42M |
| Accumulated Other Comp. Income | -$223K | -$223K | -$223K | -$223K | -$205K | -$205K | -$205K | -$205K |
| Total Stockholders' Equity | -$5.88M | -$5.36M | -$6.57M | -$6.28M | -$5.82M | -$5.70M | -$5.68M | -$5.22M |
| Total Equity | -$5.88M | -$5.36M | -$6.57M | -$6.28M | -$5.82M | -$5.70M | -$5.68M | -$5.22M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.27M | -$668K | $1.16M | $2.44M | -$6.77M | $3.41M | -$2.62M | -$4.72M | -$5.84M | -$7.75M |
| Stock-Based Compensation | -- | $13K | $348K | -- | -- | -- | -- | -- | -- | -- |
| Change in Receivables | -$110K | -$95K | $254K | -$41K | -$110K | -$34K | -$71K | $0 | -$83K | $83K |
| Change in Payables | $821 | -$7 | $876 | -$63K | -$19K | $18K | $11K | -$415K | $255K | $215K |
| Operating Cash Flow | -$384K | -$752K | -$174K | -$607K | -$1.13M | $19K | -$482K | -$1.58M | -$1.89M | -$1.67M |
| Investing Cash Flow | -- | -- | -- | $25K | $495K | $0 | $50K | -$5.7K | $0 | -- |
| Common Stock Issued | $58K | $564K | -- | -- | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | $452K | $631K | $244K | -$94K | $1.36M | -$26K | $432K | $1.32M | $2.14M | $1.66M |
| Net Change in Cash | $69K | -$120K | $70K | -$676K | $727K | -$7.9K | -$164 | -$262K | $245K | -$14K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$638K | $992K | -$968K | -$572K | -$167K | -$19K | -$515K | -$271K |
| Change in Receivables | -$27K | -$27K | -$27K | -$28K | -$27K | -$27K | -$27K | -$28K |
| Change in Payables | $468 | $9.1K | $9.3K | $13 | -$3.2K | -$2.3K | $6.3K | $251 |
| Operating Cash Flow | -$24K | -$63K | -$198K | -$160K | -$56K | -$101K | -$66K | -$207K |
| Common Stock Issued | $0 | $50K | $192K | -- | -- | -- | -- | $28K |
| Financing Cash Flow | $24K | $59K | $133K | $228K | $56K | $103K | $66K | $146K |
| Net Change in Cash | -$32 | -$4.3K | -$65K | $68K | -$1 | $1.6K | -$581 | -$61K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -143.1% | -176.4% | -542.8% | -270.6% | -328.1% | -190.3% | -688.0% | -1425.8% | -2282.6% | -2957.0% |
| Net Profit Margin | -538.8% | -282.5% | 913.8% | 1946.8% | -11055.4% | 3104.0% | -2384.7% | -4715.2% | -5308.2% | -7750.6% |
| Return on Assets (ROA) | -464.1% | -414.8% | 327.1% | 437.1% | -558.1% | 2771.7% | -2647.3% | -2255.9% | -618.4% | -2426.9% |
| Current Ratio | 0.04x | 0.03x | 0.02x | 0.04x | 0.07x | 0.01x | 0.01x | 0.00x | 0.08x | 0.26x |
| Quick Ratio | 0.04x | 0.02x | 0.02x | 0.04x | 0.06x | 0.01x | 0.01x | 0.00x | 0.05x | 0.13x |
| Revenue Growth (YoY) | 0.0% | +86.9% | +0.8% | +105.1% | -44.4% | 0.0% | +10.0% | -9.1% | +10.0% | -47.9% |
| Net Income Growth (YoY) | -- | -157.8% | -52.7% | -- | -298.1% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -155.2% | -59.2% | -- | -212.5% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -6165.6% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +12789.9% | +108265.6% | +5342.1% | +5046.2% | -97.4% | -96.4% | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | +361.9% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -2337.3% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -339.8% | -367.4% | -350.3% | -143.1% | -127.2% | -155.6% | -170.1% | -229.6% |
| Net Profit Margin | -501.4% | -302.5% | -730.0% | -538.8% | -411.2% | -395.5% | -496.7% | -367.8% |
| Return on Assets (ROA) | -412.5% | -275.1% | -728.4% | -464.1% | -494.2% | -552.0% | -542.6% | -414.8% |
| Current Ratio | 0.05x | 0.05x | 0.03x | 0.04x | 0.03x | 0.03x | 0.03x | 0.03x |
| Quick Ratio | 0.05x | 0.05x | 0.03x | 0.04x | 0.03x | 0.03x | 0.02x | 0.02x |
| Revenue Growth (YoY) | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +86.7% | +86.7% | -- |